Core Viewpoint - A securities class-action lawsuit has been filed against Sable Offshore Corp. for allegedly misleading investors regarding the restart of its oil production, which led to significant investor losses [1][2]. Group 1: Allegations and Legal Proceedings - The lawsuit, Johnson v. Sable Offshore Corp., involves investors who purchased shares between May 19, 2025, and June 3, 2025, including those who participated in the secondary public offering on May 21, 2025 [2]. - Sable Offshore issued a press release on May 19 claiming it had restarted oil production, which was later contradicted by California's Lieutenant Governor, stating that the activities were merely "well-testing procedures" [2]. - The alleged deception was revealed on May 28, 2025, when the Lieutenant Governor's letter became public, causing Sable's stock price to drop by over 15% [3]. - On June 4, 2025, a Santa Barbara County Superior Court judge issued a temporary restraining order against Sable, preventing the company from transporting oil through the Las Flores Pipeline System, further impacting the stock price [3]. Group 2: Legal Representation and Investigation - Hagens Berman, a national shareholder rights firm, is investigating the claims against Sable Offshore and is seeking information from investors who suffered substantial losses [5]. - The firm is examining whether the company's statements regarding oil production and subsequent judicial actions were part of a pattern of misleading behavior that resulted in investor losses [5]. Group 3: Company Background - Hagens Berman is a global plaintiffs' rights complex litigation firm that focuses on corporate accountability and has secured over $2.9 billion for clients harmed by corporate negligence [6].

Core Viewpoint - Nutex Health Inc. is facing legal challenges due to a class-action lawsuit alleging deceptive billing practices that artificially inflated its financial results [1][2][9]. Group 1: Legal Allegations - The lawsuit claims Nutex collaborated with HaloMD to submit ineligible insurance claims, misleading shareholders and causing significant financial losses [1][2]. - Allegations include a systematic effort to exploit the insurance arbitration process, with thousands of questionable claims submitted to extract outsized reimbursements [2][3]. - The lawsuit asserts that Nutex's revenue model is unstable and that financial statements did not accurately reflect the company's operations [2]. Group 2: Market Reaction - Following the release of a report by Blue Orca Capital, which accused HaloMD of a fraudulent scheme, Nutex's stock dropped over 10% [3][4]. - After Nutex announced a delay in its Form 10-Q filing, shares plunged 16.39%, closing at $92.91 [6]. Group 3: Financial Reporting Issues - Nutex is accused of misrepresenting its internal control progress, particularly in misclassifying stock-based compensation obligations [5]. - The Audit Committee determined that prior financial statements required restatement due to incorrect classification of obligations related to hospital development [7]. Group 4: Investor Impact - The class-action suit seeks damages for investors who acquired Nutex securities during the alleged misrepresentation period, claiming public disclosures were materially misleading [9]. - Hagens Berman is investigating whether Nutex's business model relied on questionable arbitration tactics and if its financial reporting misled investors [10].

Core Viewpoint - Synopsys, Inc. experienced a significant drop in share price by 36% following the announcement of Q3 2025 financial results, which revealed major issues with a key foundry customer, prompting an investigation into potential misleading information provided to investors [1][4]. Financial Performance - For Q3 2025, Synopsys reported a guidance for Q4 2025 GAAP EPS ranging from negative $0.27 to negative $0.16, indicating a substantial underperformance [4]. - The share price fell over $216, marking the worst single-day percentage decline since the company went public in 1992 [1][4]. Customer Relations - Synopsys had previously assured investors that the reduction in R&D spending by its largest customer, Intel, would not significantly impact its EDA software business, citing "committed, non-cancellable" agreements [3]. - The recent earnings call revealed that challenges with a major foundry customer were significantly affecting the company's IP business and overall performance [4]. Legal and Investigative Actions - Hagens Berman, a national shareholders rights firm, has initiated an investigation into whether Synopsys misled investors regarding customer risks and growth prospects [1][5]. - The firm is encouraging investors who suffered losses to come forward and is seeking information from individuals with knowledge relevant to the investigation [2][5].

Core Viewpoint - A securities class-action lawsuit has been filed against Sable Offshore Corp. for allegedly misleading investors regarding the restart of its oil production, which led to significant investor losses [1][2]. Group 1: Allegations and Legal Proceedings - The lawsuit, Johnson v. Sable Offshore Corp., involves investors who purchased shares between May 19, 2025, and June 3, 2025, including those who participated in the secondary public offering on May 21, 2025 [2]. - Sable Offshore issued a press release on May 19 claiming it had restarted oil production, which was later contradicted by California's Lieutenant Governor, stating that the activities were merely "well-testing procedures" [2]. - The alleged deception was revealed on May 28, 2025, when the Lieutenant Governor's letter became public, causing Sable's stock price to drop by over 15% [3]. - On June 4, 2025, a Santa Barbara County Superior Court judge issued a temporary restraining order against Sable, prohibiting oil transportation through the Las Flores Pipeline System, further impacting the stock price [3]. Group 2: Legal and Investigative Actions - The lawsuit seeks to hold Sable Offshore and its underwriters accountable for raising capital under false pretenses [4]. - Hagens Berman, a national shareholder rights firm, is investigating the claims and assessing whether the company's statements about oil production and subsequent judicial actions were part of a pattern of misleading behavior [5]. - The firm has a history of securing over $2.9 billion in cases related to corporate accountability and is currently focused on this investigation [6].

Core Viewpoint - A securities class action lawsuit has been filed against Lockheed Martin Corporation, alleging that the company misled investors about its financial health and internal controls from January 23, 2024, to July 21, 2025 [1][2]. Group 1: Allegations and Misrepresentations - The lawsuit claims Lockheed Martin overstated its operational capabilities, particularly in the Aeronautics and Rotary and Mission Systems (RMS) segments, while failing to disclose inadequate internal controls [2]. - It is alleged that the company lacked effective procedures to accurately assess program requirements and risks, leading to undisclosed potential significant losses [2]. Group 2: Impact of Disclosures - A series of negative disclosures revealed the company's financial issues, resulting in significant stock price drops, including a nearly 11% decline on the final disclosure [3]. - Specific financial losses reported include $1.8 billion in pre-tax losses in the Aeronautics segment on January 28, 2025, and an additional $950 million and $570 million in pre-tax losses for the Aeronautics and RMS segments, respectively, disclosed on July 22, 2025 [6]. Group 3: Investigation and Focus - Hagens Berman is investigating the claims on behalf of affected investors, focusing on whether the losses were a foreseeable consequence of poor internal controls and miscommunication of risks [4][5]. - The investigation aims to determine if executives were aware of the inadequacies in internal controls and whether they were transparent about the risks leading to substantial write-downs [5].

SAN FRANCISCO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- A securities class-action lawsuit has been filed against Sable Offshore Corp. (NYSE: SOC) and its executives, alleging the company misled investors about the restart of its oil production off the California coast. The litigation, filed in California federal court, claims the company used a false press release to artificially inflate its stock price just before a secondary public offering (SPO), resulting in significant investor losses. Hagens Berman urges Sa ...

Core Viewpoint - A securities class action lawsuit has been filed against Lockheed Martin Corporation, alleging that the company misled investors regarding its financial health and internal controls from January 23, 2024, to July 21, 2025 [1][2]. Group 1: Allegations and Misrepresentations - The lawsuit claims Lockheed Martin overstated its operational capabilities, particularly in the Aeronautics and Rotary and Mission Systems (RMS) segments, while lacking effective internal controls to assess program risks [2][4]. - It is alleged that the company failed to disclose significant potential losses due to inadequate internal controls, which misled investors about the company's true financial condition [2][5]. Group 2: Impact of Disclosures - A series of negative disclosures led to significant stock price drops, with shares falling nearly 11% following the final disclosure [3]. - Specific financial losses reported include $1.8 billion in pre-tax losses in the Aeronautics segment on January 28, 2025, and an additional $950 million and $570 million in pre-tax losses for the Aeronautics and RMS segments, respectively, disclosed on July 22, 2025 [6]. Group 3: Investigation and Legal Actions - Hagens Berman is investigating the claims on behalf of investors who suffered substantial losses, focusing on whether the company's internal control issues were known to executives [4][5]. - The firm encourages investors with losses to contact them before the September 26, 2025, deadline for the lead plaintiff [2].

Core Viewpoint - A securities class-action lawsuit has been filed against Sable Offshore Corp. and its executives for allegedly misleading investors regarding the restart of oil production, which led to significant investor losses [1][2]. Group 1: Allegations and Legal Proceedings - The lawsuit, Johnson v. Sable Offshore Corp., represents investors who purchased shares between May 19, 2025, and June 3, 2025, including those who participated in the secondary public offering on May 21, 2025 [2]. - Sable Offshore issued a press release on May 19 claiming it had restarted oil production, which was later challenged by California's Lieutenant Governor, stating that the activities were only "well-testing procedures" [2]. - The alleged deception was revealed on May 28, 2025, when the Lieutenant Governor's letter became public, causing Sable's stock price to drop by over 15% [3]. - On June 4, 2025, a Santa Barbara County Superior Court judge issued a temporary restraining order against Sable, prohibiting oil transportation through the Las Flores Pipeline System, further impacting the stock price [3]. Group 2: Legal and Investigative Actions - The lawsuit seeks to hold Sable Offshore and its underwriters accountable for raising capital under false pretenses [4]. - Hagens Berman, a national shareholder rights firm, is investigating the claims and assessing whether the company's statements about oil production and subsequent judicial actions were part of a pattern of misleading behavior [5]. - Whistleblowers with non-public information regarding Sable Offshore are encouraged to assist in the investigation, with potential rewards under the SEC Whistleblower program [5].

Core Viewpoint - A securities class-action lawsuit has been filed against Sable Offshore Corp. and its executives, alleging that the company misled investors regarding the restart of its oil production, which led to significant investor losses [1][2]. Group 1: Allegations and Legal Proceedings - The lawsuit, Johnson v. Sable Offshore Corp., represents investors who purchased shares between May 19, 2025, and June 3, 2025, including those who participated in the secondary public offering on May 21, 2025 [2]. - Sable Offshore issued a press release on May 19 claiming it had restarted oil production, which was later challenged by California's Lieutenant Governor, stating that the activities were only "well-testing procedures" [2]. - The alleged deception was exposed on May 28, 2025, when the Lieutenant Governor's letter became public, causing Sable's stock price to plummet by over 15% [3]. Group 2: Impact on Stock and Legal Consequences - Following the exposure of the misleading statements, a Santa Barbara County Superior Court judge issued a temporary restraining order on June 4, 2025, prohibiting Sable from transporting oil through the Las Flores Pipeline System, leading to further declines in the stock price [3]. - The lawsuit seeks to hold Sable Offshore and its underwriters accountable for allegedly raising capital under false pretenses [4]. Group 3: Investigation and Whistleblower Information - Hagens Berman, a national shareholder rights firm, is investigating the claims against Sable Offshore, focusing on whether the company's statements about oil production and subsequent judicial intervention were part of a pattern of misleading behavior [5]. - Whistleblowers with non-public information regarding Sable Offshore are encouraged to consider their options to assist in the investigation or participate in the SEC Whistleblower program, which offers rewards for original information [5].

Core Viewpoint - A securities class action lawsuit has been filed against KinderCare Learning Companies, Inc. alleging that the company misled investors during its October 2024 IPO, claiming that the IPO documents presented a false image of the company's operations [1][4]. Group 1: Allegations and Claims - The lawsuit claims that KinderCare's IPO documents misrepresented the quality of care provided, stating it offered "the highest quality care possible" while concealing a history of serious safety and care failures [1][5]. - More than 30% of KinderCare's revenues are derived from federal subsidies, making the alleged omissions regarding safety and care failures particularly significant, as they expose the company to undisclosed legal and regulatory risks [2][3]. - Since the IPO, KinderCare's stock has significantly declined from an offering price of $24 per share to lows near $9 per share, attributed to the market's realization of the misleading nature of the company's positive statements [3][4]. Group 2: Legal Investigation and Actions - Hagens Berman is investigating the claims against KinderCare and encourages affected investors to consider their legal options, focusing on the alleged concealment of safety and care failures that led to an inflated IPO price [4][5]. - The firm is examining whether the failure to disclose key risks constitutes a violation of U.S. securities laws, emphasizing the disconnect between KinderCare's presentation to investors and the actual operational realities [5][6].